19-53900547-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_002739.5(PRKCG):c.1437-64T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0168 in 1,614,186 control chromosomes in the GnomAD database, including 997 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.033 ( 193 hom., cov: 32)
Exomes 𝑓: 0.015 ( 804 hom. )
Consequence
PRKCG
NM_002739.5 intron
NM_002739.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.34
Publications
11 publications found
Genes affected
PRKCG (HGNC:9402): (protein kinase C gamma) Protein kinase C (PKC) is a family of serine- and threonine-specific protein kinases that can be activated by calcium and second messenger diacylglycerol. PKC family members phosphorylate a wide variety of protein targets and are known to be involved in diverse cellular signaling pathways. PKC also serve as major receptors for phorbol esters, a class of tumor promoters. Each member of the PKC family has a specific expression profile and is believed to play distinct roles in cells. The protein encoded by this gene is one of the PKC family members. This protein kinase is expressed solely in the brain and spinal cord and its localization is restricted to neurons. It has been demonstrated that several neuronal functions, including long term potentiation (LTP) and long term depression (LTD), specifically require this kinase. Knockout studies in mice also suggest that this kinase may be involved in neuropathic pain development. Defects in this protein have been associated with neurodegenerative disorder spinocerebellar ataxia-14 (SCA14). Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]
PRKCG Gene-Disease associations (from GenCC):
- spinocerebellar ataxia type 14Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.98).
BP6
Variant 19-53900547-T-C is Benign according to our data. Variant chr19-53900547-T-C is described in CliVar as Benign. Clinvar id is 1270032.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-53900547-T-C is described in CliVar as Benign. Clinvar id is 1270032.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-53900547-T-C is described in CliVar as Benign. Clinvar id is 1270032.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-53900547-T-C is described in CliVar as Benign. Clinvar id is 1270032.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-53900547-T-C is described in CliVar as Benign. Clinvar id is 1270032.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.113 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRKCG | NM_002739.5 | c.1437-64T>C | intron_variant | Intron 13 of 17 | ENST00000263431.4 | NP_002730.1 | ||
PRKCG | NM_001316329.2 | c.1437-64T>C | intron_variant | Intron 13 of 18 | NP_001303258.1 | |||
PRKCG | XM_047439092.1 | c.1053-64T>C | intron_variant | Intron 14 of 19 | XP_047295048.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0331 AC: 5041AN: 152204Hom.: 193 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
5041
AN:
152204
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0151 AC: 22077AN: 1461864Hom.: 804 Cov.: 33 AF XY: 0.0153 AC XY: 11126AN XY: 727238 show subpopulations
GnomAD4 exome
AF:
AC:
22077
AN:
1461864
Hom.:
Cov.:
33
AF XY:
AC XY:
11126
AN XY:
727238
show subpopulations
African (AFR)
AF:
AC:
2630
AN:
33480
American (AMR)
AF:
AC:
2079
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
165
AN:
26136
East Asian (EAS)
AF:
AC:
5983
AN:
39700
South Asian (SAS)
AF:
AC:
3618
AN:
86258
European-Finnish (FIN)
AF:
AC:
204
AN:
53406
Middle Eastern (MID)
AF:
AC:
152
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
5929
AN:
1111996
Other (OTH)
AF:
AC:
1317
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
1513
3025
4538
6050
7563
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
374
748
1122
1496
1870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0332 AC: 5051AN: 152322Hom.: 193 Cov.: 32 AF XY: 0.0338 AC XY: 2521AN XY: 74488 show subpopulations
GnomAD4 genome
AF:
AC:
5051
AN:
152322
Hom.:
Cov.:
32
AF XY:
AC XY:
2521
AN XY:
74488
show subpopulations
African (AFR)
AF:
AC:
3273
AN:
41566
American (AMR)
AF:
AC:
404
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
AC:
24
AN:
3470
East Asian (EAS)
AF:
AC:
627
AN:
5178
South Asian (SAS)
AF:
AC:
243
AN:
4830
European-Finnish (FIN)
AF:
AC:
30
AN:
10624
Middle Eastern (MID)
AF:
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
AC:
374
AN:
68034
Other (OTH)
AF:
AC:
69
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
239
479
718
958
1197
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
58
116
174
232
290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
360
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
May 21, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.